ロード中...
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
BACKGROUND: The trans-membrane protease serine 2 (TMPRSS2) is essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry and infection. Efficacy and safety of TMPRSS2 inhibitors in patients with coronavirus disease 2019 (Covid-19) have not been evaluated in randomized tria...
保存先:
| 出版年: | EClinicalMedicine |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8060682/ https://ncbi.nlm.nih.gov/pubmed/33903855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100849 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|